The search term 'LYMPHOMA' revealed the following 2 open trials:
Trial Number: 08254 | Study Title: Phase I/II Dose-Escalation Study of the Pan-Histone Deacetylase (HDAC) Inhibitor PCI-24781 in Lymphoma |
Trial Number: CTSU S0816 | Study Title: A Phase II Trial of Response Adapted Therapy of Stage III-IV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging |



